EC Number | Inhibitors | Comment | Organism | Structure |
---|---|---|---|---|
3.4.22.16 | 4-aminophenylmercuric acetate | 93% inhibition at 1 mM | Homo sapiens | |
3.4.22.16 | Benzyloxycarbonyl-Phe-Phe-CHN2 | 31% inhibition at 0.01 mM | Homo sapiens | |
3.4.22.16 | chymostatin B | 47% inhibition at 0.016 mM | Homo sapiens | |
3.4.22.16 | Hyamine 1622 | 52% inhibition at 1 mM | Homo sapiens | |
3.4.22.16 | iodoacetamide | 99% inhibition at 1 mM | Homo sapiens | |
3.4.22.16 | iodoacetic acid | 99% inhibition at 1 mM | Homo sapiens | |
3.4.22.16 | iodoacetic acid | - |
Rattus norvegicus | |
3.4.22.16 | Leu-CH2Cl | 85% inhibition at 0.001 mM | Homo sapiens | |
3.4.22.16 | leupeptin | 29% inhibition at 0.021 mM | Homo sapiens | |
3.4.22.16 | leupeptin | - |
Rattus norvegicus | |
3.4.22.16 | N-ethylmaleimide | 69% inhibition at 1 mM | Homo sapiens | |
3.4.22.16 | puromycin | 36% inhibition at 1 mM | Homo sapiens | |
3.4.22.16 | Soybean trypsin inhibitor | non-specific | Homo sapiens | |
3.4.22.16 | tosyl-Leu-CH2Cl | 60% inhibition at 0.01 mM | Homo sapiens | |
3.4.22.16 | tosyl-Leu-CH2Cl | - |
Rattus norvegicus | |
3.4.22.16 | tosyl-Phe-CH2Cl | 79% inhibition at 0.01 mM | Homo sapiens |
EC Number | KM Value [mM] | KM Value Maximum [mM] | Substrate | Comment | Organism | Structure |
---|---|---|---|---|---|---|
3.4.22.16 | 0.097 | - |
Arg-2-naphthylamide | - |
Homo sapiens | |
3.4.22.16 | 0.15 | - |
Arg-4-methylcoumaryl-7-amide | - |
Homo sapiens | |
3.4.22.16 | 0.637 | - |
benzoyl-Arg-2-naphthylamide | - |
Homo sapiens |
EC Number | Molecular Weight [Da] | Molecular Weight Maximum [Da] | Comment | Organism |
---|---|---|---|---|
3.4.22.16 | 28000 | - |
- |
Homo sapiens |
3.4.22.16 | 28000 | - |
- |
Rattus norvegicus |
EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
3.4.22.16 | Homo sapiens | - |
- |
- |
3.4.22.16 | Rattus norvegicus | - |
- |
- |
EC Number | Posttranslational Modification | Comment | Organism |
---|---|---|---|
3.4.22.16 | side-chain modification | - |
Homo sapiens |
3.4.22.16 | side-chain modification | - |
Rattus norvegicus |
EC Number | Purification (Comment) | Organism |
---|---|---|
3.4.22.16 | - |
Homo sapiens |
EC Number | Source Tissue | Comment | Organism | Textmining |
---|---|---|---|---|
3.4.22.16 | liver | - |
Homo sapiens | - |
3.4.22.16 | liver | - |
Rattus norvegicus | - |
EC Number | Specific Activity Minimum [µmol/min/mg] | Specific Activity Maximum [µmol/min/mg] | Comment | Organism |
---|---|---|---|---|
3.4.22.16 | additional information | - |
- |
Homo sapiens |
3.4.22.16 | additional information | - |
- |
Rattus norvegicus |
3.4.22.16 | 0.15 | - |
substrate benzyloxycarbonyl-Arg-Arg-2-naphthylamide | Homo sapiens |
3.4.22.16 | 1.73 | - |
substrate benzoyl-DL-Arg-2-naphthylamide | Homo sapiens |
3.4.22.16 | 1.95 | - |
substrate Leu-2-naphthylamide | Homo sapiens |
3.4.22.16 | 3.5 | - |
substrate Arg-2-naphthylamide | Homo sapiens |
EC Number | Storage Stability | Organism |
---|---|---|
3.4.22.16 | 4°C or -20°C, 50-100 mM Na-acetate buffer, pH 5.5, 1 mM Na2-EDTA, 0.1% Brij 35, 5 mM Na-tetrathionate, 1 month, 0-10% loss of activity | Homo sapiens |
EC Number | Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
3.4.22.16 | alpha-N-benzoyl-DL-arginine-beta-naphthylamide + H2O | - |
Homo sapiens | alpha-N-benzoyl-DL-arginine + beta-naphthylamine | - |
? | |
3.4.22.16 | Arg-2-naphthylamide + H2O | - |
Homo sapiens | Arg + 2-naphthylamine | - |
ir | |
3.4.22.16 | Arg-2-naphthylamide + H2O | - |
Rattus norvegicus | Arg + 2-naphthylamine | - |
ir | |
3.4.22.16 | Arg-4-methylcoumaryl-7-amide + H2O | - |
Homo sapiens | Arg + 7-amino-4-methylcoumarin | - |
? | |
3.4.22.16 | benzoyl-DL-Arg-2-naphthylamide + H2O | - |
Homo sapiens | benzoyl-DL-Arg + 2-naphthylamine | - |
ir | |
3.4.22.16 | benzoyl-DL-Arg-2-naphthylamide + H2O | - |
Rattus norvegicus | benzoyl-DL-Arg + 2-naphthylamine | - |
ir | |
3.4.22.16 | Leu-2-naphthylamide + H2O | - |
Homo sapiens | Leu + 2-naphthylamine | - |
ir | |
3.4.22.16 | Leu-2-naphthylamide + H2O | - |
Rattus norvegicus | Leu + 2-naphthylamine | - |
ir |
EC Number | Subunits | Comment | Organism |
---|---|---|---|
3.4.22.16 | monomer | - |
Homo sapiens |
3.4.22.16 | monomer | - |
Rattus norvegicus |
EC Number | Synonyms | Comment | Organism |
---|---|---|---|
3.4.22.16 | alpha-N-benzoyl-arginine 2-naphthylamide hydrolase | - |
Rattus norvegicus |
EC Number | Temperature Optimum [°C] | Temperature Optimum Maximum [°C] | Comment | Organism |
---|---|---|---|---|
3.4.22.16 | 40 | - |
- |
Homo sapiens |
3.4.22.16 | 40 | - |
- |
Rattus norvegicus |
EC Number | Temperature Stability Minimum [°C] | Temperature Stability Maximum [°C] | Comment | Organism |
---|---|---|---|---|
3.4.22.16 | 50 | - |
30 min, 15% loss of activity | Homo sapiens |
3.4.22.16 | 60 | - |
30 min, 80% loss of activity | Homo sapiens |
EC Number | pH Optimum Minimum | pH Optimum Maximum | Comment | Organism |
---|---|---|---|---|
3.4.22.16 | 5 | 6 | substrate azocasein | Homo sapiens |
3.4.22.16 | 5 | 6 | substrate azocasein | Rattus norvegicus |
3.4.22.16 | 6.8 | - |
- |
Rattus norvegicus |
3.4.22.16 | 6.8 | - |
synthetic substrates | Homo sapiens |
EC Number | pH Minimum | pH Maximum | Comment | Organism |
---|---|---|---|---|
3.4.22.16 | 5 | 8 | less than 20% of maximal activity above and below | Homo sapiens |
EC Number | pH Stability | pH Stability Maximum | Comment | Organism |
---|---|---|---|---|
3.4.22.16 | additional information | - |
irreversibly inactivated at alkaline pH | Homo sapiens |
3.4.22.16 | 7 | - |
irreversible inactivation above | Homo sapiens |